Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001600136-25-000003
Filing Date
2025-02-12
Accepted
2025-02-12 16:25:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7552
2 exhibit1.htm EX-1 3994
  Complete submission text file 0001600136-25-000003.txt   13478
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Subject) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-32384 | Film No.: 25615200
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 950 THIRD AVENUE, 23RD FLOOR NEW YORK NY 10022
Business Address 950 THIRD AVENUE, 23RD FLOOR NEW YORK NY 10022 212-735-5380
Clearline Capital LP (Filed by) CIK: 0001600136 (see all company filings)

EIN.: 900934356 | State of Incorp.: DE | Fiscal Year End: 0213
Type: SCHEDULE 13G